Department of Genetics Publications for January 7th – 20th 2024
Department of Genetics faculty, postdocs, students and collaborators published 12 papers during January 7th – 20th 2024.
Department of Genetics faculty, postdocs, students and collaborators published 12 papers during January 7th – 20th 2024.
Department of Genetics faculty, postdocs, students and collaborators published 9 papers during October 8th – 21st 2023.
Department of Genetics faculty, postdocs, students and collaborators published 15 papers during April 9th – 22nd, 2023.
Department of Genetics faculty, postdocs, students and collaborators published 10 papers during March 26th – April 8th, 2023.
Department of Genetics faculty, postdocs, students and collaborators published 8 papers during March 12th – 25th, 2023. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations. Liu D, Meyer D, Fennessy B, Feng C, Cheng E, Johnson JS, Park YJ, Rieder MK, Ascolillo S, de Pins A, Dobbyn A, Lebovitch D, Moya … Read more
Christoph Rau, PhD (Assistant Professor, Genetics) has been awarded a new R01 grant from the National Heart, Lung and Blood Institute’s (NHLBI) Stephen I. Katz Early Stage Investigator Research Program for his application titled “Elucidating the Role of Multinuclearity in Healthy and Diseased Mammalian Cardiomyocytes”.
Jeremy Purvis, PhD (Associate Professor) and Christoph Rau, PhD (Assistant Professor) received an Emerging Challenges in Biomedical Research (ECBR) award from UNC School of Medicine for their project titled “Identifying the role of local cell-type neighborhoods on catecholamine-induced focal necrosis”.
Department of Genetics faculty, postdocs, students and collaborators published 17 papers during January 16th – 29th, 2022.
Department of Genetics faculty, postdocs, students and collaborators published nineteen papers during May 16-29, 2021.
Department of Genetics faculty, postdocs, students and collaborators published 18 papers during October 11-31, 2020. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, … Read more